Tag: Schizophrenia
Antipsychotic Polypharmacy Has Prevalence of 12 Percent
Diagnosis of schizophrenia, length of stay of 90 days or more are strongest predictors of polypharmacy
Smoking in Pregnancy Tied to Schizophrenia Risk for Child
Findings based on analysis of maternal levels of cotinine
Clozapine Benefits Those With Tx-Resistant Schizophrenia
Clozapine already approved for use after other antipsychotics don't work
FDA OKs Long-Acting Atypical Antipsychotic for Schizophrenia
Aristada (aripiprazole lauroxil) is injected every four-to-six weeks
fMRI May Take Guesswork Out of Schizophrenia Rx
Personalized approach could eliminate trial-and-error, hasten critical time to treatment
FDA Approves New Drug for Schizophrenia, Bipolar Disorder
Vraylar is an atypical antipsychotic taken once a day
Thalamic Dysconnectivity Seen in Those at Risk for Psychosis
Particularly pronounced among individuals who converted to full-blown illness
FDA Approves Rexulti for Schizophrenia, Depression
But shouldn't be prescribed to some older people
ARVO: Genetic Link ID’d for Strabismus and Schizophrenia
Almost half of the genes dysregulated in strabismic medial rectus muscle are schizophrenia biomarkers
FDA Approves First Generic Abilify
For treatment of bipolar disorder or schizophrenia
